Committee MeetingSenateMeeting
An oversight hearing to examine the Food and Drug Administration's foreign drug manufacturing inspection process, focusing on COVID-19 and beyond.
Held
Tuesday, June 2, 2020
Dirksen Senate Office Building 106
Held by
Senate Finance